Pursuing Health Care Value Post-COVID-19: Keep The Focus On Patients

At the midpoint of the Health Affairs and IVI blog series, PCORI's Nakela Cook discusses an essential lesson from the pandemic that must be applied to clinical research, healthcare delivery, and public health – patients must help drive the calculus that policymakers apply to building a more equitable, affordable healthcare system that delivers optimal outcomes. [...]

2021-11-19T16:10:31-05:00November 18th, 2021|Blog, Health Affairs Blog Series|

How Current Cost-Effectiveness Analyses Distort Drug Development Priorities

In the latest post in our ongoing series with Health Affairs blog, Soeren Mattke takes on the relationship value assessment and innovation of new therapies. He argues that cost-effectiveness analysis, one of the most common methods for economic assessments, may be distorting the incentives for investment in medical research and drug development. Specifically, he explains [...]

2021-11-16T17:25:11-05:00November 16th, 2021|Blog, Health Affairs Blog Series|

IVI MEMBER SPOTLIGHT: Danny van Leeuwen

This year we are pleased to welcome Danny van Leeuwen as a new member of the Innovation and Value Initiative. Danny is the host of HealthHats, a podcast and blog that helps people learn on the journey towards health. We were delighted that he took the time to speak with our own Jennifer [...]

2021-11-11T11:41:43-05:00November 9th, 2021|Blog, Member Spotlight|

Bolstering Our Ability To Value Health Technology: A Few Less-Considered Issues

AcademyHealth’s Michael E. Gluck authors the next in the IVI and Health Affairs blog series. He describes historical public efforts to implement HTA and how it “intersects with all of the major challenges facing US health care: cost, quality, access, equity, social determinants, and the tensions between the country’s dual commitments to innovation and health [...]

2021-11-10T14:05:09-05:00November 9th, 2021|Blog, Health Affairs Blog Series|

Fair Prices Should Lead To Fair Access: Why Is The Grand Bargain So Hard?

In a new post in our ongoing blog series with Health Affairs, ICER's Sarah Emond discusses the challenge of achieving a "grand bargain" in which fair prices and fair access provide optimal benefits to both patients and the health system. At the root, she argues, is the different and sometimes-conflicting perspectives, objectives, and incentives of the [...]

2021-11-02T17:13:44-04:00November 2nd, 2021|Blog, Health Affairs Blog Series|

The US Should Change Payment To Make Health Care More Equitable

The Health Affairs series continues with a post by Amol Navathe, Risa Lavizzo-Mourey and Joshua Laio examining how fee for service and risk-based payments fuel inequities and four ways we can set an explicit intention to use payments to eradicate inequities. The authors’ four recommendations: Form diverse coalitions with shared principles focused on payment Create [...]

2021-10-26T13:34:34-04:00October 26th, 2021|Blog, Health Affairs Blog Series|

How COVID Can Help Us Refocus On The How And Why Of Value Assessment

Our second post in the Health Affairs blog series explores how value assessment can bridge the gap between healthcare consumption and payment decisions. Mark Linthicum, Darius Lakdawalla, and Chuck Phelps discuss emerging methods to capture scientific spillover, patients’ lived experience, and risk. Read the full blog post here. The Innovation and Value Initiative [...]

2021-10-26T13:35:31-04:00October 21st, 2021|Blog, Health Affairs Blog Series|

The Future Of Value Assessment In A Post-Pandemic United States

We begin our Health Affairs blog series with the Global Liver Institute’s Donna Cryer sharing insights on how the pandemic has altered our views about how we measure value and how it influences access to quality care. Donna offers three axioms for value assessment: 1) We are all connected; 2) We are all essential; [...]

2021-10-26T13:35:44-04:00October 19th, 2021|Blog, Health Affairs Blog Series|

Value Must Be Inclusive

Author: Rick Chapman, PhD, Chief Science Officer In the context of value assessment, what does patient representativeness mean? A new infographic from IVI, "Value assessment should serve diverse populations and the organizations that provide their care," shows the wide-ranging breadth of factors that comprise patient representativeness. IVI endeavors to fully integrate the patient experience [...]

2021-10-15T13:33:07-04:00October 15th, 2021|Blog|

IVI MEMBER SPOTLIGHT: The Assistance Fund

Over the summer, we sat down with Stephanie Marshall, Director of Advocacy from The Assistance Fund to learn more about the organization and their priorities for the future of value assessment. Tell us a little about your organization. The Assistance Fund (TAF) is an independent 501(c)3 patient assistance organization. We help [...]

2021-10-26T13:36:13-04:00September 27th, 2021|Blog, Member Spotlight|
Go to Top